Intermittent Androgen Deprivation Therapy With or Without Stereotactic Body Radiation Therapy for Molecularly Identified Hormone Sensitive Oligometastatic Prostate Cancer

Official Title

Intermittent Androgen Deprivation Therapy With or Without Stereotactic Body Radiation Therapy for Molecularly Identified Hormone Sensitive Oligometastatic Prostate Cancer: A Randomized Feasibility Study

Summary:

This study is evaluating whether adding stereotactic radiation therapy (a new, more focused type of radiation therapy) to treat all the tumours that are present will improve outcomes or not compared to drugs alone for patients who are negative on conventional imaging and positive on PSMA PET scan

Trial Description

Primary Outcome:

• Proportion of eligible patients who enroll onto the study

• Side Effects and Effectiveness

View this trial on ClinicalTrials.gov